Health / Medical Topics

    Immunocytokine NHS-IL12

    A fusion protein consisting of the heavy-chains of the human antibody NHS76, raised against DNA released by necrotic tumor cells, and fused to two molecules of a genetically modified human interleukin-12 (IL-12) with potential immunostimulating and antineoplastic activities. Upon administration, the antibody moiety of immunocytokine NHS-IL12 binds to DNA released from necrotic tumor cells located primarily at the core of necrotic solid tumors, thereby delivering the IL-12 moiety. In turn, the IL-12 moiety of this agent stimulates the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth. IL-12 is a proinflammatory cytokine with numerous immunoregulatory functions and may augment host immune responses to tumor cells. By targeting tumor cells, NHS-IL-12 may reduce the toxicity associated with systemic administration of recombinant human IL-12. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A laboratory tissue staining procedure involving monoclonal or polyclonal antibodies that react with specific tissue antigens. Initially used as a research…
    A combination of 3 fluorescent-tagged monoclonal antibodies. Recently licensed for screening of bladder cancer recurrence by urine test.
    A type of treatment that uses an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance…
    An immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3), with potential antineoplastic…
    An agent that consists of an immune substance, such as a monoclonal antibody, antigen or an immunoglobulin, and covalently bound to other…
    Having a weakened immune system caused by certain diseases or treatments.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact